ArticleFrontiers in endocrinology2025
Impaired thyroid hormone sensitivity is associated with the degrees of fatty infiltration in metabolic dysfunction associated steatotic liver disease.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As a chronic disease, MASLD seriously endangers human health and has a complex pathogenesis. Thyroid hormones (THs) play significant roles in this process. We aimed to analyze the correlation between TH sensitivity and the degrees of fatty infiltration in MASLD. Methods: We conducted a retrospective study on a sample of 13,144 individuals who underwent physical examinations. Thyroid function, liver and kidney function, blood lipids, and glucose were measured using chemiluminescence methods. TH sensitivity indexes, including free triiodothyronine to free thyroxine ratio (FT3/FT4), thyroid feedback quantile-based index (TFQI), thyroid-stimulating hormone index (TSHI), and thyrotropin thyroxine resistance index (TT4RI), were calculated. The degree of liver fatty infiltration [controlled attenuation parameter (CAP)] was determined by liver shear wave quantification ultrasonography. We then conducted statistical analyses of the above data. Results: FT3/FT4, TFQI, TSHI, and TT4RI showed significantly increasing trends with the rise of CAP levels (p < 0.001). In males, high CAP levels of CAP were negatively correlated with FT3/FT4 (β [95% CI]: -0.005 [-0.008, -0.002]; p = 0.0004) but positively correlated with TSHI (β [95% CI]: 0.019 [0.002, 0.036]; p = 0.0248) and TFQI (β [95% CI]: 0.015 [0.003, 0.027]; p = 0.01371). In the BMI <28 kg/m² group, low CAP levels of CAP were positively correlated with FT3/FT4 (β [95% CI]: 0.002 [0.002, 0.003]; p < 0.00001), while high CAP levels of CAP were positively correlated with TFQI (β [95% CI]: 0.016 [0.000, 0.031]; p = 0.04805). Conclusions: TH sensitivity is significantly impaired in MASLD. This phenomenon is more pronounced in males and in individuals with BMI <28 kg/m².
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.